Accovion supports CSL Behring in successfully obtaining marketing authorisation for Berinert Berinert, a human C1 esterase inhibitor (C1-INH) for treating acute episodes of facial or abdominal hereditary angioedema
Biovitrum has completed the first of two clinical phase II studies, designed to together show proof of concept of Kiobrina (rhBSSL) in preterm infants. The results show statistically
Ipsen has initiated an international, multi-center, controlled, randomised Phase II clinical trial to evaluate the safety and efficacy of BN83495, its investigational steroid sulfatase (STS) inhibitor, in advanced
Novartis has gained exclusive rights to two oral targeted investigational therapies for patients with a range of life-threatening blood disorders and cancers that currently do not have effective
Unilife Medical Solutions has filed patent applications in the US for a new ready-to-fill syringe product to be marketed as the Unifill Select. The Unifill Select is a
Nanosphere has received 510(k) clearance from the FDA to update its package insert for its Verigene Respiratory Virus Nucleic Acid Test on Verigene SP System (RVNATSP). It is
LFB Biotechnologies’ (LFB) recombinant anti-CD20 monoclonal antibody received orphan drug status for the treatment of chronic lymphocytic leukemia (CLL). The company received the approval from the EMEA’s Committee
Gen-Probe’s subsidiary, Prodesse has received FDA clearence for marketing its ProParaflu+ assay in the US. Its a molecular test that detects and differentiates parainfluenza 1, 2 and 3
QLT has announced the settlement of its litigation with the General Hospital, doing business as Massachusetts General Hospital (MGH). Under the terms of the settlement agreement, QLT will
Catalent Pharma Solutions (Catalent) has appointed Paul Burns as a new vice president of global sales. In this newly created role, Mr. Burns will be responsible for developing
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.